# Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke

> **NCT06696820** · PHASE2,PHASE3 · RECRUITING · sponsor: **Xiang Luo** · enrollment: 429 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** PCSK9 inhibitors combined with atorvastatin/rosuvastatin
- **DRUG:** Atorvastatin/Rosuvastatin

## Key facts

- **NCT ID:** NCT06696820
- **Lead sponsor:** Xiang Luo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-29
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 429 (ESTIMATED)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06696820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06696820, "Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06696820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*